Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris.

Bioscience reports - 31 Oct 2018

Cheng Jing, Su Xing, Qiao Lei, Zhai Chungang, Chen Wenqiang

Abstract excerpt

There is increasing evidence that serum adipokine levels are associated with higher risks of cardiovascular diseases. As an important adipokine, fibroblast growth factor 21 (FGF21) has been demonstrated to be associated with atherosclerosis and coronary artery disease (CAD). However, circulating level of FGF21 in patients with angina pectoris has not yet been investigated. Circulating FGF21 level was examined in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Angina, Unstable
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Coronary Artery Disease

Share to Fibroblast Growth Factors

Share to Risk Factors

Share to Troponin I

Source

Open in PubMed Open full text

Identifiers

PMID: 30185439
DOI: 10.1042/BSR20181099
PMCID: PMC6153373

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris.PMID 30185439Read ↗

Mechanism of fibroblast growth factor 21 in cardiac remodelingSemantic proximity Read ↗

The role of miR-21 as a biomarker and therapeutic target in cardiovascular diseaseSemantic proximity Read ↗

Genetic evidence supporting fibroblast growth factor 21 signalling as a pharmacological target for cardiometabolic outcomes and Alzheimer's diseaseSemantic proximity Read ↗

Predictive value of Serum CCL21 and CCL19 levels in heart failure patients : A prospective studySemantic proximity Read ↗

MiR-21-3p regulation FGFR1/FGF21/PPARγ pathway induces atrial fibrosis by targeting FGFR1 in diabetesSemantic proximity Read ↗

FGF21 defines a potential cardio-hepatic signaling circuit in human heart failureSemantic proximity Read ↗

Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease.Semantic proximity Read ↗

The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.Semantic proximity Read ↗

Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.Semantic proximity Read ↗

Fgf21 is required for cardiac remodeling in pregnancy.Semantic proximity Read ↗

Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21.Semantic proximity Read ↗

9p21.3 coronary artery disease risk locus and interferon alpha 21: Association study in an Asian Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.